This message was posted by a user wishing to remain anonymous
Hello, Could you please respond if you have experience with pre-IND meeting request with CBER - what was the timeframe between when the pre-IND meeting is requested to when it is granted (meeting date)?
I heard there is a long lead time - is that your recent experience. Is CBER is not keeping up with timeframe in FDA's meeting guidance (i.e. 60 days for type B)?
Also, for Pre-IND briefing book/Pharmacology studies - is a single species ok? and do the studies have to be GLP?
Thanks in advance!